Key result
iNOS inhibition reduces vascular smooth muscle cell viability by ~30% following mechanical stretch.
Why the study?
Aortic dissection and aneurysm are linked to hypertension-related hemodynamic loads, and cyclic mechanical stretch causes MAPK-dependent rat aortic smooth muscle cell death. The role of inducible nitric oxide synthase in cyclic mechanical stretch-induced smooth muscle cell death required investigation.
Does inducible nitric oxide synthase (iNOS) upregulation protect rat aortic smooth muscle cells against cyclic mechanical stretch-induced cell death?
Does inducible nitric oxide synthase (iNOS) upregulation protect rat aortic smooth muscle cells against cyclic mechanical stretch-induced cell death?
Inducible nitric oxide synthase (iNOS) and subsequent low-level NO production, regulated independently by p38 MAPK and STAT1 pathways, play a protective role against mechanical stretch-induced vascular smooth muscle cell death during early acute hypertension.
Answers are grounded in this paper and cite their sources.
iNOS-derived NO may protect stretched vascular cells; hypothesis-generating and should not yet change practice.
Aortic dissection and aneurysm are associated with abnormal hemodynamic loads originating from hypertension. Our previous study demonstrated that cyclic mechanical stretch (CMS, mimicked hypertension) caused the death of rat aortic smooth muscle cells (RASMCs) in a mitogen activated-protein kinases (MAPKs)-dependent manner. The current study investigated the effects of inducible nitric oxide synthase (iNOS) on CMS-induced RASMC death. cDNA microarrays for CMS-treated RASMCs showed that iNOS expression levels were increased in response to CMS. Real-time polymerase chain reaction (PCR) analysis demonstrated that this increase was p38 MAPK (p38)-dependent. NO production was also increased. This increase could be inhibited by p38 and iNOS inhibitors. Thus, CMS-induced iNOS synthesized NO. CMS-induced cell death in RASMCs was increased by the iNOS inhibitor but abrogated by the long-acting NO donor DETA-NONOate. Increased iNOS expression was confirmed in the abdominal aortic constriction mouse model. Signal transducers and activators of transcription 1 (STAT1) was activated in stretched RASMCs, and iNOS expression and NO production were inhibited by the STAT1 inhibitor nifuroxazide. Our findings suggest that RASMCs were protected by iNOS from CMS-stimulated cell death through the STAT1 and p38 signal pathways independently.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2020) studied Hypertension-induced vascular remodeling / aortic dissection and aneurysm (preclinical rat aortic smooth muscle cell and mouse abdominal aortic constriction models). Cyclic mechanical stretch (CMS) with iNOS inhibitor (1400 W), NO donor (DETA-NONOate), p38 inhibitor (SB203580), or STAT1 inhibitor (nifuroxazide) vs. CMS alone or unstretched control cells / sham-operated mice was evaluated on Cell viability and death of RASMCs subjected to cyclic mechanical stretch (p=<0.05). Inhibition of iNOS with 1400 W (50 nM) decreased RASMC viability by 30%, whereas the NO donor DETA-NONOate (2 µM) improved viability by 25% following cyclic mechanical stretch.
Synapse has enriched 10 related papers. Consider them for comparative context: